Stock 1780 ALLIED BIOTECH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Allied Biotech Corporation

Equities

1780

TW0001780005

Food Processing

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-07-16 pm EDT 		5-day change 1st Jan Change
18.35 TWD +1.66% Intraday chart for Allied Biotech Corporation +3.09% +11.21%
Apr. 23 Allied Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Allied Biotech Corporation Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,541 1,666 1,603 1,454 1,340 1,580
Enterprise Value (EV) 1 1,445 1,598 1,644 1,559 1,384 1,651
P/E ratio 11.5 x 15.7 x 20.3 x 111 x 9.18 x 16.3 x
Yield 6.14% 5.69% 4.75% 3.28% 8.54% 5.15%
Capitalization / Revenue 2.01 x 2.61 x 2.59 x 2.15 x 1.87 x 2.19 x
EV / Revenue 1.89 x 2.5 x 2.66 x 2.3 x 1.93 x 2.29 x
EV / EBITDA 7.28 x 8.44 x 10.4 x 9.14 x 8.38 x 10.8 x
EV / FCF 20.5 x 26.3 x -104 x 26.2 x 79 x 50 x
FCF Yield 4.88% 3.8% -0.96% 3.81% 1.27% 2%
Price to Book 1.36 x 1.44 x 1.4 x 1.34 x 1.13 x 1.35 x
Nbr of stocks (in thousands) 94,600 94,890 95,152 95,351 95,385 95,785
Reference price 2 16.29 17.56 16.85 15.25 14.05 16.50
Announcement Date 3/19/19 3/13/20 3/9/21 3/11/22 3/28/23 5/6/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 765.3 639.4 618.1 676.8 716.7 720.4
EBITDA 1 198.4 189.2 158.1 170.5 165.1 152.4
EBIT 1 145.4 136.5 102.6 111.7 99.78 88.71
Operating Margin 19% 21.35% 16.59% 16.5% 13.92% 12.31%
Earnings before Tax (EBT) 1 164.3 136 101.5 17.58 185 122.4
Net income 1 133.5 106.9 79.47 13.04 146.7 97.41
Net margin 17.44% 16.72% 12.86% 1.93% 20.47% 13.52%
EPS 2 1.411 1.120 0.8300 0.1368 1.530 1.010
Free Cash Flow 1 70.55 60.74 -15.8 59.42 17.52 33.04
FCF margin 9.22% 9.5% -2.56% 8.78% 2.44% 4.59%
FCF Conversion (EBITDA) 35.56% 32.1% - 34.85% 10.61% 21.68%
FCF Conversion (Net income) 52.85% 56.82% - 455.62% 11.94% 33.91%
Dividend per Share 2 1.000 1.000 0.8000 0.5000 1.200 0.8500
Announcement Date 3/19/19 3/13/20 3/9/21 3/11/22 3/28/23 5/6/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 40.5 105 44.1 70.7
Net Cash position 1 95.6 68.7 - - - -
Leverage (Debt/EBITDA) - - 0.2562 x 0.6159 x 0.2669 x 0.4637 x
Free Cash Flow 1 70.6 60.7 -15.8 59.4 17.5 33
ROE (net income / shareholders' equity) 12.1% 9.34% 6.91% 1.17% 13% 8.28%
ROA (Net income/ Total Assets) 5.24% 4.56% 3.05% 2.97% 2.7% 2.6%
Assets 1 2,549 2,344 2,608 439.3 5,441 3,744
Book Value Per Share 2 12.00 12.20 12.00 11.30 12.40 12.20
Cash Flow per Share 2 2.650 4.310 7.390 7.940 7.130 6.460
Capex 1 43.7 42.2 56.8 50 54.7 47.9
Capex / Sales 5.71% 6.6% 9.19% 7.39% 7.63% 6.65%
Announcement Date 3/19/19 3/13/20 3/9/21 3/11/22 3/28/23 5/6/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
ALLIED BIOTECH CORPORATION Stock Allied Biotech Corporation
+11.21% 53.92M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+19.81% 8.6B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
-6.80% 6.72B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
-14.67% 5.04B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-6.54% 3.71B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-21.43% 3.13B
HERBALIFE LTD. Stock Herbalife Ltd.
-23.20% 1.17B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-17.45% 1.13B
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-1.83% 944M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-11.94% 899M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. 1780 Stock
  4. Financials Allied Biotech Corporation